Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Healthtrust
AstraZeneca
Queensland Health
Chinese Patent Office
Farmers Insurance
Cipla
QuintilesIMS
Covington

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: RE37035

« Back to Dashboard

Summary for Patent: RE37035
Title: Phenylacetic acid benzylamides
Abstract:Phenylacetic acid benzylamides having the following general structure ##STR1## wherein the substituents are defined herein, are disclosed, which compounds are hypoglcemic agents.
Inventor(s): Grell; Wolfgang (Biberach, DE), Hurnaus; Rudolf (Biberach, DE), Griss; Gerhart (late of Biberach, DE), Sauter; Robert (Laupheim, DE), Reiffen; Manfred (Biberach, DE), Rupprecht; Eckhard (Guntramsdorf, AT)
Assignee: Boehringer Ingelheim KG (Ingelheim, DE)
Application Number:08/946,602
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent RE37035

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE37035

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3347565Dec 30, 1983
Germany3522604Jun 25, 1985
Germany3523466Jul 01, 1985

International Patents Family Members for US Patent RE37035

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 44027 ➤ Subscribe
Austria 52255 ➤ Subscribe
Austria 53028 ➤ Subscribe
Australia 3721084 ➤ Subscribe
Australia 577815 ➤ Subscribe
Australia 583631 ➤ Subscribe
Australia 587263 ➤ Subscribe
Australia 5913986 ➤ Subscribe
Australia 5938386 ➤ Subscribe
Bulgaria 61519 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
US Department of Justice
Fuji
AstraZeneca
Covington
Healthtrust
Julphar
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot